IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClose Bros Regulatory News (CBG)

Share Price Information for Close Bros (CBG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 461.00
Bid: 455.80
Ask: 458.00
Change: 45.00 (10.82%)
Spread: 2.20 (0.483%)
Open: 421.80
High: 461.00
Low: 420.40
Prev. Close: 416.00
CBG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of a Prospectus

8 Jun 2021 14:52

RNS Number : 2133B
Close Brothers Group PLC
08 June 2021
 

8 June 2021

NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES OR ITS TERRITORIES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF, U.S. PERSONS OR OTHERWISE THAN TO PERSONS TO WHOM IT CAN LAWFULLY BE DISTRIBUTED

CLOSE BROTHERS GROUP PLC

PUBLICATION OF PROSPECTUS

The following prospectus has been approved by the Financial Conduct Authority and is available for viewing:

Prospectus dated 8 June 2021 relating to the issue of £200,000,000 2.00% Subordinated Tier 2 Notes by Close Brothers Group plc as issuer (the "Prospectus").

To view the full Prospectus, please paste the following URL into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/2133B_1-2021-6-8.pdf

The Prospectus will also be available for viewing at the National Storage Mechanism and will shortly be available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.For further information, please contact:

John HudspithGroup Deputy Company SecretaryClose Brothers Group plcLEI code: 213800W73SYHR14I3X9110 Crown PlaceLondon EC2A 4FT+44 (0) 20 3857 6059

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Prospectus is not addressed. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

In particular, neither this announcement nor the Prospectus shall constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction.

The securities described in the Prospectus have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") or any relevant securities laws of any state of the United States. The securities may not be offered or sold within the United States or to or for the account or benefit of U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The Prospectus may not be accessed from, or transmitted in or into, the United States.

Your right to access this service is conditional upon complying with the above requirements.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PDIXVLFBFQLZBBV
Date   Source Headline
2nd Jul 20245:30 pmRNSDirector/PDMR Shareholding
28th Jun 20245:00 pmRNSTotal Voting Rights
26th Jun 20245:00 pmRNSBoard Committee Changes
25th Jun 20245:00 pmRNSDirector/PDMR Shareholding
6th Jun 20243:00 pmRNSDirector/PDMR Shareholding
31st May 20244:00 pmRNSTotal Voting Rights
30th May 20243:00 pmRNSDirector/PDMR Shareholding
22nd May 20247:00 amRNSTrading Statement
16th May 20244:00 pmRNSDirector/PDMR Shareholding
8th May 20244:00 pmRNSDirector/PDMR Shareholding
30th Apr 20245:00 pmRNSTotal Voting Rights
24th Apr 20243:30 pmRNSDirector/PDMR Shareholding
23rd Apr 20241:00 pmRNSNotice of Quarterly Trading Update
23rd Apr 202410:00 amRNSDirector/PDMR Shareholding
22nd Apr 20241:00 pmRNSDirector/PDMR Shareholding
16th Apr 20244:00 pmRNSHolding(s) in Company
16th Apr 202410:00 amRNSHolding(s) in Company
12th Apr 20245:15 pmRNSHolding(s) in Company
11th Apr 20242:00 pmRNSHolding(s) in Company
8th Apr 20245:00 pmRNSDirector/PDMR Shareholding
4th Apr 202410:30 amRNSHolding(s) in Company
2nd Apr 202410:00 amRNSDirector/PDMR Shareholding
28th Mar 20243:00 pmRNSTotal Voting Rights
28th Mar 20242:45 pmRNSHolding(s) in Company
27th Mar 20242:30 pmRNSHolding(s) in Company
26th Mar 20245:30 pmRNSHolding(s) in Company
22nd Mar 202411:30 amRNSDirector/PDMR Shareholding
19th Mar 20245:00 pmRNSHolding(s) in Company
19th Mar 20247:00 amRNSHalf-year Report for six months to 31 January 2024
18th Mar 20247:00 amRNSHolding(s) in Company
15th Mar 20242:30 pmRNSHolding(s) in Company
6th Mar 20246:00 pmRNSDirector/PDMR Shareholding
29th Feb 20245:30 pmRNSTotal Voting Rights
29th Feb 20244:30 pmRNSHolding(s) in Company
20th Feb 20243:45 pmRNSHolding(s) in Company
19th Feb 20242:00 pmRNSHolding(s) in Company
15th Feb 20245:00 pmRNSDirectorate Change
15th Feb 20247:00 amRNSTrading Statement and Dividend Announcement
6th Feb 20245:30 pmRNSDirector/PDMR Shareholding
6th Feb 20244:00 pmRNSHolding(s) in Company
31st Jan 20245:30 pmRNSTotal Voting Rights
16th Jan 20245:00 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSTransaction in Own Shares
11th Jan 202412:00 pmRNSDirector/PDMR Shareholding
8th Jan 20246:00 pmRNSDirector/PDMR Shareholding
8th Jan 20245:45 pmRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
28th Dec 20239:29 amRNSPost-Stabilisation Notice - Close Brothers AT1
27th Dec 20235:30 pmRNSTransaction in Own Shares
22nd Dec 202312:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.